10 Spam-Free Article(s) Found
Sort:
Like
Filter:
All
Article Searches
10 of the Best REITs for 2024 https://www.fool.com/investing/2023/12/12/10-of-the-best-reits-for-2024/?source=iedfolrf0000001 Dec 12, 2023 - REITs are expected to rebound in 2024.
Bull Market Buys: 3 Dividend Stocks to Own for the Long Run https://www.fool.com/investing/2023/12/26/bull-market-buys-3-dividend-stocks-to-own-for-the/?source=iedfolrf0000001 Dec 26, 2023 - These dividend stocks could start their own bull run in 2024 as their headwind fades.
Applied Therapeutics' NDA For Govorestat Gets Priority Review From FDA; Stock Soars In Pre-Market https://www.rttnews.com/story.aspx?Id=3428203 Feb 28, 2024 - Applied Therapeutics, Inc. (APLT), Wednesday announced that the U.S. Food and Drug Administration had accepted the filing of the New Drug Application or NDA for Govorestat for the treatment of galactosemia and granted a priority review.
3 Stocks That Make the Perfect Investment for the Average Retiree Looking for Passive Income https://www.fool.com/investing/2024/01/08/3-stocks-that-make-the-perfect-investment-for-the/?source=iedfolrf0000001 Jan 08, 2024 - These REITs can reliably roll in the income while you reel in the years.
Anavex (AVXL) Rises as CHMP Deems Blarcamesine Eligible for MAA https://www.zacks.com/stock/news/2200597/anavex-avxl-rises-as-chmp-deems-blarcamesine-eligible-for-maa?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2200597 Dec 20, 2023 - The CHMP agrees that Anavex's (AVXL) blarcamesine for Alzheimer's disease is eligible for submission for a Union Marketing Authorisation in the EU. Shares rise.
What's in the Cards for Kimco (KIM) This Earnings Season? https://www.zacks.com/stock/news/2221904/what-s-in-the-cards-for-kimco-kim-this-earnings-season?cid=CS-ZC-FT-analyst_blog|earnings_preview-2221904 Feb 06, 2024 - The resilient demand for Kimco's (KIM) grocery-anchored centers, a diverse tenant base and a focus on mixed-use assets are likely to have aided its Q4 earnings despite higher interest expenses.
Mid-America Apartment Communities (MAA) Reports Q4 Earnings: What Key Metrics Have to Say https://www.zacks.com/stock/news/2222976/mid-america-apartment-communities-maa-reports-q4-earnings-what-key-metrics-have-to-say?cid=CS-ZC-FT-fundamental_analysis|nfm-2222976 Feb 07, 2024 - While the top- and bottom-line numbers for Mid-America Apartment Communities (MAA) give a sense of how the business performed in the quarter ended December 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Watch These 3 Residential REITs for Q1 Earnings: Beat or Miss? https://www.zacks.com/stock/news/2264440/watch-these-3-residential-reits-for-q1-earnings-beat-or-miss?cid=CS-ZC-FT-analyst_blog|earnings_preview_-_esp-2264440 Apr 29, 2024 - Residential REITs are likely to have gained from portfolio diversification and technological initiatives in Q1, though high supply and elevated interest rates are likely to have acted as dampeners.
Mid-America Apartment (MAA) Q1 FFO Lags Estimates, Revenues Beat https://www.zacks.com/stock/news/2267245/mid-america-apartment-maa-q1-ffo-lags-estimates-revenues-beat?cid=CS-ZC-FT-analyst_blog|earnings_article-2267245 May 02, 2024 - While Mid-America Apartment's (MAA) Q1 results reflect an increase in the average effective rent per unit, a decline in average physical occupancy for the same-store portfolio and higher expenses act as a dampener.
Compared to Estimates, Mid-America Apartment Communities (MAA) Q1 Earnings: A Look at Key Metrics https://www.zacks.com/stock/news/2267858/compared-to-estimates-mid-america-apartment-communities-maa-q1-earnings-a-look-at-key-metrics?cid=CS-ZC-FT-fundamental_analysis|nfm-2267858 May 03, 2024 - The headline numbers for Mid-America Apartment Communities (MAA) give insight into how the company performed in the quarter ended March 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Pages: 1

Page 1